The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?

被引:4
|
作者
Han, Ji Whan [1 ]
机构
[1] Catholic Univ Korea, Dept Pediat, Yeouido St Marys Hosp, Coll Med, 10,63-Ro, Seoul 07345, South Korea
关键词
GAMMA-GLOBULIN; THERAPY; MODULATE; SYSTEM;
D O I
10.4070/kcj.2017.0011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:179 / 181
页数:3
相关论文
共 50 条
  • [1] Intravenous immunoglobulin for the treatment of Kawasaki disease
    Broderick, Cathryn
    Kobayashi, Shinobu
    Suto, Maiko
    Ito, Shuichi
    Kobayashi, Tohru
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (01):
  • [2] Intravenous Immunoglobulin for the Treatment of Kawasaki Disease
    Shulman, Stanford T.
    PEDIATRIC ANNALS, 2017, 46 (01): : E25 - E28
  • [3] Role of intravenous immunoglobulin in the treatment of Kawasaki disease
    Lo, Mindy S.
    Newburger, Jane W.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (01) : 64 - 69
  • [4] Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease
    Kuo, Ho-Chang
    Hsu, Yu-Wen
    Wu, Mei-Shin
    Chien, Shu-Chen
    Liu, Shih-Feng
    Chang, Wei-Chiao
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (01) : 1 - 7
  • [5] Predictors of Intravenous Immunoglobulin Resistance in Chinese Children with Kawasaki Disease
    Young, J. H. M.
    Huen, K. F.
    Chan, L. T. W.
    HONG KONG JOURNAL OF PAEDIATRICS, 2013, 18 (04) : 204 - 209
  • [6] Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
    Li, Wei
    Zhang, Li
    Wang, Zhouping
    He, Xiufang
    Lin, Huimei
    Wang, Yanfei
    Yuan, Jia
    Xie, Xiaofei
    Zhang, Xu
    Qin, Youzhen
    Huang, Ping
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022
  • [7] Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing
    Yang, Shuai
    Song, Ruixia
    Zhang, Junmei
    Li, Xiaohui
    Li, Caifeng
    ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 (03) : 262 - 267
  • [8] High-dose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease
    Nolan, Brian E.
    Wang, Yunfei
    Pary, Philippe P.
    Luban, Naomi L. C.
    Wong, Edward C. C.
    Ronis, Tova
    TRANSFUSION, 2018, 58 (11) : 2564 - 2571
  • [9] Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial
    Fukui, Saori
    Seki, Mitsuru
    Minami, Takaomi
    Kotani, Kazuhiko
    Oka, Kensuke
    Yokomizo, Akiko
    Matsubara, Daisuke
    Sato, Tomoyuki
    Nozaki, Yasuyuki
    Saito, Mari
    Kikuchi, Yutaka
    Miyamoto, Kenji
    Monden, Yukifumi
    Yamagata, Takanori
    PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)
  • [10] High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more
    Suzuki, Takanori
    Michihata, Nobuaki
    Yoshikawa, Tetsushi
    Hata, Tadayoshi
    Matsui, Hiroki
    Fushimi, Kiyohide
    Yasunaga, Hideo
    EUROPEAN JOURNAL OF PEDIATRICS, 2020, 179 (12) : 1901 - 1907